Drug-induced immune thrombocytopaenia: Results from the Berlin Case-Control Surveillance Study

European Journal of Clinical Pharmacology

Volumn 68, Issue 5, 2012, Pages 821-832

  Garbe, Edeltraut ^a,b   Andersohn, Frank ^a   Bronder, Elisabeth ^a   Salama, Abdulgabar ^a   Klimpel, Andreas ^a   Thomae, Michael ^c   Schrezenmeier, Hubert ^d   Hildebrandt, Martin ^e   Späth Schwalbe, Ernst ^f   Grüneisen, Andreas ^g   Meyer, Oliver ^a   Kurtal, Hanife ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c Abteilung Innere Medizin Gastroenterologie   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f Vivantes Klinikum Spandau   (Germany)

^g VIVANTES KLINIKUM NEUKÖLLN   (Germany)

Author keywords

Acute immune thrombocytopaenia; Case control study; Drug dependent antibodies; Drug induced; Vaccines

Indexed keywords

ABCIXIMAB; AMLODIPINE; CARBAMAZEPINE; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CITALOPRAM; CLOPIDOGREL; COTRIMOXAZOLE; DICLOFENAC; DROSPIRENONE PLUS ETHINYLESTRADIOL; EPTIFIBATIDE; FUROSEMIDE; GENTAMICIN; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; IBUPROFEN; INDAPAMIDE PLUS PERINDOPRIL; INFLUENZA VACCINE; LORAZEPAM; MELPERONE; NITROFURANTOIN; PENICILLIN G; PENICILLIN V; POLIOMYELITIS VACCINE; RISPERIDONE; SPIRONOLACTONE; TERAZOSIN; TIROFIBAN; UNINDEXED DRUG; VALPROIC ACID;

ADULT; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; CASE CONTROL STUDY; CAUSAL ATTRIBUTION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EXPOSURE; DRUG IDENTIFICATION; DRUG INDUCED DISEASE; DRUG INDUCED IMMUNE THROMBOCYTOPENIA; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HOSPITAL PATIENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; THROMBOCYTE COUNT;

ACUTE DISEASE; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-INFECTIVE AGENTS; AUTOANTIBODIES; BERLIN; CASE-CONTROL STUDIES; FEMALE; HOSPITALS, URBAN; HUMANS; INFLUENZA VACCINES; LOGISTIC MODELS; MALE; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECURRENCE; RISK; SULFONAMIDES;

EID: 84864290624     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1184-3     Document Type: Article

References (44)

1. Aster RH, Bougie DW (2007) Drug-induced immune thrombocytopenia. N Engl J Med 357(6):580-587 (Pubitemid 47236283)
2. Kenney B, Stack G (2009) Drug-induced thrombocytopenia. Arch Pathol Lab Med 133(2):309-314
3. Kang SY, Choi JC, Kang JH, Lee JS (2010) Acute subdural hemorrhage associated with rifampicin-induced thrombocytopenia. Neurol Sci 31(2):199-200
4. Kolluri VR, Reddy DR, Reddy PK, Naidu MR, Kumari CS (1986) Subdural hematoma secondary to immune thrombocytopenic purpura: case report. Neurosurgery 19(4):635-636 (Pubitemid 16006320)
5. Single report database for drug-induced thrombocytopenia: An update. http://www.ouhsc.edu/platelets/InternetPostingLitSingleFrames2-18-11.htm. Accessed 13 September 2011
6. George JN, Aster RH (2009) Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematol Am Soc Hematol Educ Program:153-158
7. Visentin GP, Liu CY (2007) Drug-induced thrombocytopenia. Hematol Oncol Clin North Am 21(4):685-696, vi (Pubitemid 47102560)
8. Van den Bemt PM, Meyboom RH, Egberts AC (2004) Druginduced immune thrombocytopenia. Drug Saf 27(15):1243-1252
9. Database for drug-induced thrombocytopenia from Group Patient Reports: an update. http://www.ouhsc.edu/platelets/InternetPostingLitGroup2-18-11.htm. Accessed 13 September 2011
10. George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T (1998) Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 129 (11):886-890 (Pubitemid 28549817)
11. Aster RH, Curtis BR, McFarland JG, Bougie DW (2009) Druginduced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost 7(6):911-918
12. Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK (2010) Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood 116 (12):2127-2133
13. Warkentin TE, Anderson JA (2010) DITP causation: 3 methods better than 1? Blood 116(12):2002-2003
14. Kaufman DW, Kelly JP, Johannes CB, Sandler A, Harmon D, Stolley PD, Shapiro S (1993) Acute thrombocytopenic purpura in relation to the use of drugs. Blood 82(9):2714-2718 (Pubitemid 23318077)
15. ten Berg MJ, Huisman A, Souverein PC, Schobben AF, Egberts AC, van Solinge WW, van den Bemt PM (2006) Drug-induced thrombocytopenia: a population study. Drug Saf 29(8):713-721 (Pubitemid 44175042)
16. Bertuola F, Morando C, Menniti-Ippolito F, Da Cas R, Capuano A, Perilongo G, Da Dalt L (2010) Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy. Drug Saf 33(1):65-72
17. Andersohn F, Bronder E, Klimpel A, Garbe E (2004) Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-control Surveillance Study. Am J Hematol 77 (3):316-318 (Pubitemid 39430715)
18. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88(1):3-40 (Pubitemid 26230668)
19. The Uppsala Monitoring Centre. The use of the WHO-UMC system for standardised case causality assessment. http://www.who-umc.org/Graphics/24734. pdf. Accessed 13 September 2011
20. World Health Organization. The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD). http://www.who.int/ classifications/atcddd/en/. Accessed 13 September 2011
21. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C (1987) Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 70(6):1722-1726 (Pubitemid 18055614)
22. Kiefel V (1992) The MAIPA assay and its applications in immunohaematology. Transfus Med 2(3):181-188
23. Meyer O, Gaedicke G, Salama A (1999) Demonstration of drugdependent antibodies in two patients with neutrophenia and successful treatment with granulocyte-colony-stimulating factor. Transfusion 39(5):527-530 (Pubitemid 29233278)
24. Schwabe U, Paffrath D (2009) Arzneiverordnungsreport 2009. Springer Medizin Verlag, Heidelberg
25. Said SM, Hahn J, Schleyer E, Muller M, Fiedler GM, Buerke M, Prondzinsky R (2007) Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment. Clin Res Cardiol 96 (2):61-69 (Pubitemid 46233207)
26. Curtis BR, Swyers J, Divgi A, McFarland JG, Aster RH (2002) Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets. Blood 99 (6):2054-2059 (Pubitemid 34525488)
27. Jubelirer SJ, Koenig BA, Bates MC (1999) Acute profound thrombocytopenia following C7E3 Fab (Abciximab) therapy: case reports, review of the literature and implications for therapy. Am J Hematol 61(3):205-208 (Pubitemid 29297891)
28. Vahdat B, Canavy I, Fourcade L, Garcia E, Quilici J, Bonnet JL, Bory M (2000) Fatal cerebral hemorrhage and severe thrombocytopenia during abciximab treatment. Catheter Cardiovasc Interv 49 (2):177-180 (Pubitemid 30075543)
29. Coons JC, Barcelona RA, Freedy T, Hagerty MF (2005) Eptifibatide- associated acute, profound thrombocytopenia. Ann Pharmacother 39(2):368-372 (Pubitemid 40165232)
30. Curtis BR, Divgi A, Garritty M, Aster RH (2004) Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug. J Thromb Haemost 2(6):985-992 (Pubitemid 40185747)
31. Nurden P, Clofent-Sanchez G, Jais C, Bermejo E, Leroux L, Coste P, Nurden AT (2004) Delayed immunologic thrombocytopenia induced by abciximab. Thromb Haemost 92(4):820-828 (Pubitemid 39386710)
32. Dickson HG (1978) Trimethoprim-sulphamethoxazole and thrombocytopenia. Med J Aust 2(1):5-7 (Pubitemid 9013515)
33. Keisu M, Wiholm BE, Palmblad J (1990) Trimethoprim-sulphamethoxazole- associated blood dyscrasias. Ten years' experience of the Swedish spontaneous reporting system. J Intern Med 228(4):353-360 (Pubitemid 20337478)
34. Rothman KJ (1981) Induction and latent periods. Am J Epidemiol 114(2):253-259 (Pubitemid 11051959)
35. Leach MF, Aubuchon JP (1999) Frequency of thrombocytopenia associated with gentamicin therapy. Immunohematology 15 (4):167-170
36. Wraith DC, Goldman M, Lambert PH (2003) Vaccination and autoimmune disease: what is the evidence? Lancet 362 (9396):1659-1666 (Pubitemid 37443537)
37. Jadavji T, Scheifele D, Halperin S (2003) Thrombocytopenia after immunization of Canadian children, 1992 to 2001. Pediatr Infect Dis J 22(2):119-122 (Pubitemid 36228127)
38. Casoli P, Tumiati B (1989) Acute idiopathic thrombocytopenic purpura after anti-influenza vaccination. Medicina (Firenze) 9 (4):417-418 (Pubitemid 20128591)
39. Ikegame K, Kaida K, Fujioka T, Kawakami M, Hasei H, Inoue T, Taniguchi Y, Yoshihara S, Hayashi S, Kurata Y, Ogawa H (2006) Idiopathic thrombocytopenic purpura after influenza vaccination in a bone marrow transplantation recipient. Bone Marrow Transplant 38(4):323-324 (Pubitemid 44203787)
40. Tishler M, Levy O, Amit-Vazina M (2006) Immune thrombocytopenic purpura following influenza vaccination. Isr Med Assoc J 8 (5):322-323 (Pubitemid 43805047)
41. Wagner K (1964) Protrahierte Thrombozytopenie nach Polymyelitis Schutzimpfung. Wien Med Wochenschr 114:628-631
42. Wise RP, Iskander J, Pratt RD, Campbell S, Ball R, Pless RP, Braun MM (2004) Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine. JAMA 292(14):1702-1710 (Pubitemid 39346672)
43. Altintas E, Oguz D, Kacar S, Ozderin Y, Sezgin O, Zengin NI (2004) Dydrogesterone-induced hepatitis and autoimmune hemolytic anemia. Turk J Gastroenterol 15(1):49-52 (Pubitemid 38737762)
44. Kacar S, Akdogan M, Kosar Y, Parlak E, Sasmaz N, Oguz P, Aydog G (2002) Estrogen and cyproterone acetate combination-induced autoimmune hepatitis. J Clin Gastroenterol 35 (1):98-100 (Pubitemid 34663361)